FDA is changing the therapeutic equivalence rating for Accord Healthcare Inc. ’s generics of Prograf (tacrolimus) oral capsules  

Based on new data, the U.S. Food and Drug Administration is changing the therapeutic equivalence rating for tacrolimus oral capsule products manufactured by Accord Healthcare Inc. under abbreviated new drug application 091195.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news